A Phase I Study of Aerosolized Administration of tgAAVCF to Cystic Fibrosis Subjects with Mild Lung Disease

囊性纤维化 医学 遗传增强 不利影响 囊性纤维化跨膜传导调节器 载体(分子生物学) 气溶胶化 内科学 腺相关病毒 免疫学 胃肠病学 药理学 生物 基因 麻醉 遗传学 吸入 重组DNA
作者
Moira L. Aitken,Richard B. Moss,David A. Waltz,Mark Dovey,Mark R. Tonelli,Sharon McNamara,Ronald L. Gibson,Bonnie W. Ramsey,Barrie J. Carter,Thomas C. Reynolds
出处
期刊:Human Gene Therapy [Mary Ann Liebert]
卷期号:12 (15): 1907-1916 被引量:231
标识
DOI:10.1089/104303401753153956
摘要

Cystic fibrosis (CF) is one of the most common autosomal recessive disorders in North America, leading to significant morbidity and early mortality. The defect in the cystic fibrosis transmembrane conductance regulator protein (CFTR) function can be corrected in vitro by gene replacement with a wild-type gene. A Phase I, single administration, dose escalation trial was designed and executed to assess safety and delivery of tgAAVCF, an adeno-associated virus (AAV) vector encoding the human CFTR cDNA, by nebulization to the lungs of CF subjects. Four cohorts of three subjects each were administered increasing doses of the study agent, beginning with 1010 DNase-resistant particles (DRP) and escalating in log increments up to 1013 DRP. Sequential bronchoscopies were performed to gather analytical samples throughout the study. All 12 subjects completed the study. There were a total of 242 adverse events (AEs), six of which were defined as serious and three of which were defined as possibly being related to the study drug. A clear dose-response relationship was observed in vector gene transfer. A maximum of 0.6 and 0.1 vector copies per brushed cell were observed 14 days and 30 days, respectively, following nebulization of 1013 DRP tgAAVCF, and this declined to nearly undetectable levels by day 90. Vector gene transfer was evenly distributed throughout the fourth airway generation following single-dose administration. RNA-specific PCR did not detect vector-derived mRNA. This Phase I trial shows that aerosolized tgAAVCF is safe and widely delivered to the proximal airways of CF subjects by nebulization.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
禹子骞发布了新的文献求助10
刚刚
Evelvon完成签到,获得积分10
1秒前
1秒前
1秒前
1秒前
卡尔拉完成签到,获得积分10
1秒前
rivalsdd完成签到,获得积分10
2秒前
aaa完成签到,获得积分10
3秒前
华仔应助嗑瓜子传奇采纳,获得10
3秒前
lk、发布了新的文献求助10
4秒前
CYAA完成签到,获得积分10
4秒前
4秒前
我可不会发布了新的文献求助30
5秒前
keyangouderic完成签到,获得积分10
5秒前
坚强荧荧发布了新的文献求助10
7秒前
8秒前
8秒前
传统的裘完成签到,获得积分10
9秒前
迷路访云完成签到 ,获得积分10
9秒前
10秒前
wang发布了新的文献求助10
13秒前
没有逗应助lk、采纳,获得30
13秒前
糖糖发布了新的文献求助10
14秒前
ccccc关注了科研通微信公众号
15秒前
坚强荧荧完成签到,获得积分20
16秒前
17秒前
我可不会完成签到,获得积分10
18秒前
沉默的半凡完成签到,获得积分10
19秒前
不知道发布了新的文献求助10
19秒前
sail完成签到,获得积分10
20秒前
情怀应助li采纳,获得10
20秒前
20秒前
21秒前
深情安青应助威武冷雪采纳,获得10
21秒前
23秒前
jr完成签到,获得积分10
24秒前
26秒前
赵zhao发布了新的文献求助10
27秒前
橖子小姐发布了新的文献求助10
27秒前
28秒前
高分求助中
The Oxford Handbook of Social Cognition (Second Edition, 2024) 1050
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
COSMETIC DERMATOLOGY & SKINCARE PRACTICE 388
Case Research: The Case Writing Process 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3141717
求助须知:如何正确求助?哪些是违规求助? 2792627
关于积分的说明 7803778
捐赠科研通 2448954
什么是DOI,文献DOI怎么找? 1302939
科研通“疑难数据库(出版商)”最低求助积分说明 626683
版权声明 601244